Beckman CoulterBeckman Coulter Inc, Brea, Calif, a wholly owned subsidiary of Danaher Corp, Washington, DC, introduces UniCel DxH 600 Coulter cellular analysis system, a new benchtop hematology analyzer for mid- to high-volume laboratories.

The system—complete with recently FDA-cleared advanced software—provides labs with high-quality results, improved first-pass accuracy, and automatic rerun and reflex testing, thereby reducing overall manual review rates and processes.

The hematology lab’s single most important step, and most time-consuming, is the manual review. By reducing manual differential rates, the new analyzer frees mid- to high-volume labs to focus time on quickly and accurately reporting patient results, improving patient health and reducing the overall cost of care.

The software saves time by allowing labs to partially release patient results manually or automatically via decision rules.

Software features include the ability to track workload by the day, hour, and test, as well as providing automatic notification of STAT samples that have not been processed or released within an expected time frame, helping users to report STAT results in a timely and efficient manner.

With the same technology, user interface, and consumables as the UniCel DxH 800 Coulter cellular analysis system, the new model brings true standardization of results and process to the hematology lab, reducing lab personnel training and simplifying lab consumable inventory management. To further enhance standardization, all new DxH 800 analyzers will be installed with the advanced software; and current DxH 800 customers will be upgraded.

[Source: Beckman Coulter]